PPD Signs Risk-Sharing Deal with Indian Generics Company Ranbaxy
Wilmington, N.C.-based contract research organization (CRO) PPD has licensed investigational statin RBx-10558 from India-based generics company Ranbaxy Laboratories, which recently began developing novel drugs.
inVentiv Health Makes Two More Acquisitions and Reports Strong Revenues
Somerset, N.J.-based inVentiv Health, a life science communications company with a contract research organization (CRO) unit, reported a nearly 40% jump in revenues to $766.2 million in 2006. For its fourth quarter, inVentiv reported revenues jumped 21% to $211.8 million.
Other breaking news...
Company Profile: An interview with Jules Mitchel, managing director, ACTN, and president Target Health, Asian Clinical Trial Network (ACTN)
To read the full articles for this issue or for more information on these and other breaking stories, please click here for subscription information.